Reproductive Endocrinology
From the Journals
Injectable male contraceptive on par with other reversible options
An injectable male contraceptive combining long-acting testosterone and progestogen achieves near-complete yet reversible suppression of sperm...
From the Journals
Resveratrol may reduce androgen levels in PCOS
The naturally occurring polyphenol resveratrol may have beneficial hormonal effects in women with polycystic ovary syndrome (PCOS), according to...
Conference Coverage
Resveratrol cut androgen levels in small PCOS trial
SALT LAKE CITY –
Conference Coverage
Psychological stress did not harm IVF outcomes
SALT LAKE CITY – Rates of ultrasound-confirmed pregnancy did not differ based on self-reported depressive symptoms, stress, or anxiety.
Conference Coverage
Low serum AMH predicted miscarriage after IVF
Low serum levels of anti-Müllerian hormone predicted miscarriage after in vitro fertilization and embryo transfer, according to a single-center...
From the Journals
Unexplained subfertility in RA linked to periconceptional NSAID use
Women with rheumatoid arthritis are more often diagnosed with unexplained subfertility, compared with women in the general population, according...
News
European Commission’s proposed criteria for endocrine disruptors trigger multiple concerns
Conference Coverage
Oocyte donation may up risk of preterm birth
HELSINKI – The risk of preterm birth and low birth weight is higher following oocyte donation for in vitro fertilization, compared with autologous...
News
Triptorelin doesn’t prevent ovarian failure in young women treated for lymphoma
Key clinical point: The GnRH agonist triptorelin failed to prevent chemotherapy-induced premature ovarian failure in young women with lymphoma....
Conference Coverage
Weight loss may improve fertility in anovulatory obese women
HELSINKI – A 6-month lifestyle intervention was associated with an increased natural conception rate in infertile anovulatory obese women,...
Conference Coverage
Jury still out on value of r-HGH with IVF
HELSINKI, FINLAND – Recombinant human growth hormone, or r-HGH, offered no advantage over placebo with respect to improving the live birth rate...